S2 Genomics, Inc. — Form D
S2 Genomics, Inc. of LIVERMORE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-21. The offering totals $2.5M, of which $2.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-05-21
- Form: D
- Accession: 0001797955-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.2M
- Remaining: $283K
- Investors: 17
- Date of first sale: 2021-04-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-400128
Issuer
- Name: S2 Genomics, Inc.
- CIK: 0001797955
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2016
- Address: 6712 PRESTON AVE, STE D, LIVERMORE, CA, 94551
- Phone: (925) 292-8243
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Michael Finney | Director | Beverly, MA |
| Shannon Hall | Director | Livermore, CA |
| Stevan Jovanovich | Director | Pleasanton, CA |
| Peter Wagner | Director | Menlo Park, CA |
| Michael Wiley | Director | Redwood City, CA |
| Stevan Jovanovich | Executive Officer | Pleasanton, CA |
| Peter Wagner | Executive Officer | Menlo Park, CA |
| Roger McIntosh | Director | Livermore, CA |
Other filings by this issuer (1)
More